EVOLVE (EVALUATION OF CINACALCET THERAPY TO LOWER CARDIOVASCULAR EVENTS)

Serial Number 78905226
606

Registration Progress

Application Filed
Jun 9, 2006
Under Examination
Nov 27, 2007
Approved for Publication
Aug 15, 2007
Published for Opposition
Sep 4, 2007
Registered

Trademark Image

EVOLVE (EVALUATION OF CINACALCET THERAPY TO LOWER CARDIOVASCULAR EVENTS)

Basic Information

Serial Number
78905226
Filing Date
June 9, 2006
Published for Opposition
September 4, 2007
Abandonment Date
December 27, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 27, 2010
Classes
042

Rights Holder

Amgen Inc.

03
Address
One Amgen Center Drive
Thousand Oaks, CA 913201799

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
Mark I. Feldman, Christina L. Martini, Monica L. Thompson, Keith W. Medansky, Linda Urbanik Johnson, Gina L. Durham, Amy C. Ziegler and Nicole A. Chaudhari

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Dec 27, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 27, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jun 2, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2010 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 27, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2010 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 14, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 14, 2010 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 25, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2009 EXT4 S SOU EXTENSION 4 FILED Loading...
May 26, 2009 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 22, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2009 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 1, 2008 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 1, 2008 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 25, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2008 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 2, 2008 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 22, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2008 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 27, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 4, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 15, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Jul 30, 2007 ALIE A ASSIGNED TO LIE Loading...
Jul 30, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 18, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 12, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 12, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 1, 2007 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 1, 2007 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 28, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 27, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 27, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 30, 2006 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 30, 2006 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 20, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 26, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 26, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 14, 2006 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research, namely conducting clinical trials
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"EVALUATION OF CINACALCET THERAPY TO LOWER CARDIOVASCULAR EVENTS"